BACKGROUND: Leptin, a hormone which is produced by adipose tissue, has been shown to inhibit food intake and increase energy expenditure. In humans, leptin levels are correlated with body fat. In addition, leptin levels decline in subjects who lose weight. Yet few data exist on whether leptin levels predict weight change, except for a recent report suggesting that low leptin levels predict weight gain in very obese middle-aged Pima Indians. METHODS: We have examined the association between baseline leptin levels and subsequent weight gain over 3.25 y in 180 non-diabetic participants in the Mexico City Diabetes Study. RESULTS: At baseline, the correlation between leptin levels and body mass index (BMI) was 0.712 in men and 0.691 in women (both P`0.001). Subjects were matched on age (AE 2 y), gender and BMI (AE 2 kgam 2 ) at baseline. Baseline BMI was 25.3 kgam 2 in men and 27.2 kgam 2 in women. Baseline leptin levels (ngaml) did not predict weight gain in either men (weight gainers: 4.3; weight stable: 5.8; and weight losers: 5.2) or women (weight gainers: 17.4; weight stable: 17.7; and weight losers: 17.4). CONCLUSIONS: We conclude that baseline leptin levels did not predict weight change in moderately obese individuals.
Introduction
The gene responsible for obesity in the obaob mouse was recently cloned, along with its human analogue. 1 The human OB gene is expressed in several tissues, especially adipose tissue. 2 ± 4 The product of the OB gene (leptin) is thought to regulate appetite, food intake and energy expenditure. 5 ± 7 Since obese individuals overexpress leptin it has been suggested that such subjects may be resistant to its effects. 3, 4, 8 Administration of leptin to obaob mice reduces their body weight. 7 Obese humans have increased levels of this hormone. 9, 10 Furthermore, leptin levels decline in subjects who lose weight. 9, 10 However, few data are available on whether leptin levels predict future weight change; one could speculate that individuals who have high leptin levels (that is, perhaps resistant to its effects) might gain more weight. Alternatively, subjects with lower leptin levels might gain more weight due to inadequate suppression of food intake. In a study of 36 very obese Pima Indians (mean body weight of 102 kg at baseline), subjects with low leptin levels gained more weight than those with high leptin levels. 11 In this report, we examine the relationship of baseline leptin concentrations to subsequent weight change over 3.25 y in moderately obese, non-diabetic participants in the Mexico City Diabetes Study. 12 
Methods
In Mexico City, six low-income neighborhoods (colonias) were selected for the study. 12, 13 Complete enumeration of these colonias was carried out from February 1990 to October 1992 and 3326 individuals (men and non-pregnant women aged 35±64 y) were identi®ed as eligible for the study. Of these, 2813 (84.5%) completed a home interview and 2278 completed a medical examination at a clinic (response rate 68.5%). Subjects who attended the clinic examination were similar to those who only provided a home interview, in terms of age, gender, and selfreported history of myocardial infarction, diabetes and cigarette smoking. The protocol was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio, and all subjects gave informed consent.
In April 1993, we began a 3.25 y follow-up to determine the incidence of type 2 diabetes.
14 The median follow-up was 3.2 y and the range of followup was 3.0±3.8 y. The response rate to the follow-up examination was 77.6%. Subjects who attended the follow-up examination were similar to those who failed to return for follow-up examination in terms of age, gender and self-reported diabetes, myocardial infarction and cigarette smoking. Identical methods were used at both the baseline and the follow-up of the survey. Ninety-seven out of the 1449 initially nondiabetic subjects had developed non-insulin-dependent diabetes mellitus (NIDDM) at the 3.25 y follow-up. Subjects who had NIDDM at baseline or had developed NIDDM at follow-up are excluded from this report. Height, weight, waist and hip circumference were measured using previously described methods. 15 The waist-to-hip ratio (WHR) was used as a measure of body fat distribution. Body mass index (BMI) (weight (kg)aheight (m)
2 ) was used as a measure of overall adiposity. At baseline and follow-up, blood specimens were obtained after a 12±14 h fast, for determination of serum insulin and plasma glucose concentrations. Glucose and insulin concentrations were also measured 2 h after a standardized 75 g oral glucose load. Plasma insulin was measured by a solid phase radioimmunoassay that shows a relatively high degree of cross-reactivity with insulin precursors. 16 In this report, we initially measured leptin levels in 60 subjects, who gained weight over the 3.25 y follow-up (upper 10% of the distribution of weight gain; b5.9 kg in men and b7.1 kg in women), who were matched to 60 subjects who maintained stable weight (AE 2 kg weight change) (range of weight gain; À0.4±1.9 kg in men and 0.2±1.9 kg in women). These two groups were matched on age, gender and baseline BMI (AE 2 kgam 2 ) to the weight gainers. Leptin levels were also measured of 60 subjects who lost weight (lowest 10% of weight distribution of weight gain) (À1.5 to À10.9 kg in men and À2.9 to À18.7 kg in women). These subjects were also matched to weight gainers on age, gender and baseline BMI (AE 2 kam 2 ). IGT and diabetes were classi®ed at baseline and follow-up, according to World Health Organization criteria. 17 Subjects who gave a history of diabetes and who at the time of their clinic examination were taking either insulin or oral antidiabetic agents, were then considered to have diabetes, regardless of their plasma glucose values. Serum was stored in Mexico City in a À70
C freezer until being shipped to San Antonio in dry ice at approximately 4±6-week intervals. Shipments arrived in San Antonio within 12 h of being sent. Although certain measurements were also made in Mexico City for clinical purposes (for example, glucose and cholesterol), all study measurements were made at San Antonio in the Division of Clinical Epidemiology laboratory.
Aliquots of fasting (07.00±09.00 h) serum specimens were saved as contingency samples and were frozen at À70
C for an average of 6 y. (Previous studies have indicated that leptin levels may show diurnal variation.) The serum samples (for leptin) were not thawed until the assays were performed. Leptin concentrations were measured by a commercial radioimmunoassay (Linco Research Inc., St Louis, MO). 18, 19 The intraassay coef®cient of variation was 3.4±8.3% and interassay coef®cient of variation was 3.6±6.2%. The duration of storage for samples from the three groups of subjects by weight gain category, was very similar (60±61 months).
Data analysis in this report included analyses of variance ( Table 1, Table 2 and Table 4 ) and Spearman correlation analyses (Table 3) . Key variables (BMI, waist and leptin) were normally distributed within each gender. Data analyses was done using the SAS statistical software. Table 1 and Table 2 show the clinical characteristics of the weight gainer, weight stable and weight loser groups, separately by gender. At baseline, the correlation between leptin levels and BMI was 0.712 in men and 0.691 in women (both P`0.001). In men (Table  1) , the change in weight over 3.25 y was 8.5 kg for weight gainers, 0.6 kg in weight stable subjects and À2.6 kg in weight losers (P`0.001). At baseline, leptin concentrations (ngaml) were not signi®cantly different among weight gainers (4.3), weight stable subjects (5.8) and weight losers (5.2) (P 0.160). Initial BMI (P 0.765) and age (P 0.978) were very similar in the three groups. Among women (Table 2) , the change in weight was 10.5 kg in weight gainers, 0.2 kg in weight stable individuals, and À3.9 kg in weight losers (P 0.001). Baseline leptin concentrations (ngaml) were very similar among weight gainers (17.4), weight stable subjects (17.7) and weight losers (17.4). Baseline BMI and age did not differ by weight change category (P 0.978 and P 0.987, respectively). We tested whether the effect between weight gain and baseline leptin levels might differ by gender. In a two-way analysis of variance, the interaction term was 0.903 (not signi®-cant). In order to gain greater statistical power, we combined the men and women and adjusted for gender. In these analyses, leptin levels were not signi®cantly to weight change (P 0.912).
In Table 3 , we explore the association between weight change and baseline variables. Leptin concentrations at baseline were not correlated with weight change in either men (r 7 0.172, P 0.115) or women (r 0.046, P 0.672). Initial weight, age, fasting insulin and waist circumference were also not signi®cantly related to weight change in either men or women.
The subjects in the current report gained less weight than the 19 subjects reported on by Ravussin et al 11 (9.5 kg vs 23 kg, respectively). In order to better compare our data to those of Ravussin et al 11 we selected the 19 subjects with the greatest weight increase (mean weight change 14 kg) and compared them to subjects who lost the most weight at followup (mean weight loss À3.0 kg), but who were also matched on initial BMI, gender and age. These results are shown in Table 4 . As in the full data set shown in Table 1 , the individuals who gained weight, did not have signi®cantly different leptin levels at baseline than those who lost weight.
Discussion
We have shown that baseline leptin concentrations do not predict subsequent weight change in 180 nondiabetic Mexican subjects in a 3.25 y follow-up. Subjects were matched on age and BMI at baseline. (At baseline, the relationship between leptin and BMI was similar to that previously shown in well de®ned Leptin concentrations do not predict weight gain: The Mexico City Diabetes Study SM Haffner et al populations. 9, 10, 18, 19 ) Our data are in contrast to those of Ravussin et al 11 who showed in 36 subjects that low leptin levels predicted weight gain. Ravussin et al 11 suggested that low leptin levels could form part of the`thrifty' genotype, which has been postulated to explain the high rate of obesity and diabetes in native Americans. 20 The Pima Indian subjects 11 were much more obese than the Mexican subjects in this report and also had greater weight gain. However, the percentage gain in the Pima subjects 11 was only moderately greater than in the analyses presented in Table 4 . In the Pima report, slightly more men were in the weight gainer group (14a19) compared to the weight stable group (11a17); this could partly explain the lower leptin concentrations, since women have higher leptin levels than men. However, this is unlikely to explain completely the differences between the two reports. Finally, an ethnic difference could be postulated. However, the Mexican population has approximately 45% native American admixture. 12 In a previous report on the Pima population, decreased insulin sensitivity predicted weight gain. 21 However, in neither the Pima Indian report on leptin 11 nor in the current report, was insulin concentration at baseline, associated with weight gain. However, there were only a small number of subjects in these studies. We have previously reported that higher insulin levels predict weight loss in non-diabetic Mexican-American subjects. 22 Insulin concentrations 10, 23 and insulin resistance 23 ± 26 have been previously shown to be correlated with leptin concentrations. However, after further adjustment for fasting insulin, our results are basically unchanged (data not shown).
To date, few abnormalities in the DNA sequence for the OB gene have been reported in subjects with morbid obesity. 27 ± 29 Recently, Montague et al 29 have reported two very obese Pakistani children with mutations in the OB gene (and de®ciency of leptin). Although this mutation may be very rare, it is possible that a heterozygote state may exist with some in¯u-ence on obesity. Relatively weak evidence for genetic linkage of obesity to the leptin gene, has been seen in a few families with morbid obesity. 30, 31 Results on the linkage of obesity with the OB gene have been contradictory. Although some studies have failed to ®nd linkage between the OB gene and obesity in Pima Indians or Mexican-Americans, 32, 33 our group has reported evidence of linkage between this region and several indicators of obesity. 34 Interestingly, we also detected strong evidence of linkage (lod 4.2) between this region on insulin precursors (split proinsulin).
In conclusion, we failed to ®nd evidence that baseline levels of leptin predict either weight gain or weight loss in Mexicans, a population characterized to moderate levels of obesity. 
